Manufacturer of Polyzene-F nanocoating technology-based medical devices and products intended for the treatment of cardiovascular disease and addressing the treatment gap in patients at high risk of bleeding.
1
Funding Rounds
$20.8m
Money raised
The company CeloNova BioSciences has raised a total of $20.84m in funding over 1 rounds.